<code id='AB86316A11'></code><style id='AB86316A11'></style>
    • <acronym id='AB86316A11'></acronym>
      <center id='AB86316A11'><center id='AB86316A11'><tfoot id='AB86316A11'></tfoot></center><abbr id='AB86316A11'><dir id='AB86316A11'><tfoot id='AB86316A11'></tfoot><noframes id='AB86316A11'>

    • <optgroup id='AB86316A11'><strike id='AB86316A11'><sup id='AB86316A11'></sup></strike><code id='AB86316A11'></code></optgroup>
        1. <b id='AB86316A11'><label id='AB86316A11'><select id='AB86316A11'><dt id='AB86316A11'><span id='AB86316A11'></span></dt></select></label></b><u id='AB86316A11'></u>
          <i id='AB86316A11'><strike id='AB86316A11'><tt id='AB86316A11'><pre id='AB86316A11'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          Wikipedia

          author:explore    - browse:77671
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          hotspot